| 5/24/2024 | BKBWCACVHYLM | Lionsgate expects lower leverage after split from Lionsgate Studios
|
| 1/5/2024 | BKBWCACVHYLM | Lionsgate expects $300 million of deleveraging from combination funds
|
| 12/22/2023 | BKCVHY | Lionsgate to maintain current debt structure in business combination
|
| 3/24/2021 | BKCVDDEMIGPV | Market Commentary: Royal Caribbean upsizes new deal; loanDepot, Teine Energy at a premium; Lions Gate lags
|
| 11/24/2020 | BKCVDDHY | Moody's lowers Lions Gate
|
| 1/17/2020 | BKCVDDHY | S&P cuts Lions Gate
|
| 10/23/2019 | BKCVHY | S&P puts Lion’s Gate ratings on CreditWatch negative
|
| 10/17/2019 | BKCVHY | Moody’s places Lions Gate on review for downgrade
|
| 1/24/2019 | BKCVHY | Moody's rates Lions Gate notes B2
|
| 1/24/2019 | BKCVHY | S&P rates Lions Gate notes B-
|
| 10/14/2016 | BKCVDDEMIGPV | Market Commentary: Primary quiet to close out $770 million week; UCP slates deal; Lions Gate, Warner continue rise
|
| 10/13/2016 | BKCVDDEMIGPV | Market Commentary: Warner Music, Lions Gate price, gain; Horizon shops deal; Rackspace rises; funds lose $72 million
|
| 10/3/2016 | BKCVDDEMIGPV | Market Commentary: N&W Global Vending adds to building calendar; inVentive recent deal slips; ‘go-tos’ mixed
|
| 9/30/2016 | BKCVHY | S&P rates Lions Gate debt B-
|
| 9/30/2016 | BKCVHY | Moody’s: Lions Gate bonds B2
|
| 9/23/2016 | BKCVHY | S&P cuts Lions Gate, rates facility BB-
|
| 7/1/2016 | BKCVHY | S&P keeps Lions Gate on watch
|
| 7/1/2016 | BKCVHY | Moody’s reviews Lions Gate
|
| 4/1/2016 | BKCVHY | Moody’s: Lions Gate view to negative
|
| 3/16/2016 | BKCVHY | S&P puts Lions Gate on watch
|
| 4/28/2015 | BKCVHY | S&P: Lions Gate unchanged after add-on
|
| 3/16/2015 | BKCVHY | Moody's: Lions Gate unchanged
|
| 3/2/2015 | BKCVHY | S&P assigns BB- to Lions Gate loan
|
| 3/2/2015 | BKCVHY | Moody’s assigns Ba3 to Lions Gate loan
|
| 1/6/2015 | BKCVHY | S&P upgrades Lions Gate
|
| 5/5/2014 | BKCVHY | S&P: Lions Gate Entertainment view now positive
|
| 7/22/2013 | BKCVHY | S&P: Lions Gate unchanged
|
| 7/9/2013 | BKCVHY | Moody's rates Lions debt Ba3
|
| 7/9/2013 | BKCVHY | S&P: Lions Gate notes, loan B+
|
| 6/14/2013 | BKCVHY | S&P lifts Lions Gate
|
| 2/12/2013 | BKCACVHY | Lions Gate sees 130% rise in fiscal third-quarter revenue; free cash flow tops $125 million
|
| 10/26/2012 | BKCV | S&P lifts Lions Gate outlook
|
| 3/26/2012 | BKCACVHY | Moody's: Hunger Games helps Lions Gate's review
|
| 3/26/2012 | CV | Market Commentary: Investment-grade issues dominate convertibles market; Medtronic higher; MF Global dips
|
| 1/27/2012 | BKCACVHY | S&P upgrades Lions Gate
|
| 1/18/2012 | BKCACVHY | S&P puts Lions Gate on positive watch
|
| 8/29/2011 | BKCACVHY | S&P: Lions Gate to positive
|
| 5/9/2011 | BKCVHY | S&P cuts Lions Gate notes
|
| 3/30/2011 | CVLM | New York Supreme Court dismisses Icahn lawsuit against Lions Gate
|
| 1/26/2011 | BKCVHY | S&P affirms Lions Gate, removes from developing watch
|
| 12/23/2010 | CVLM | Icahn to prosecute Lions Gate exchange challenge to final judgment
|
| 10/15/2010 | BKCACVHY | S&P puts Lions Gate on developing watch
|
| 7/26/2010 | CVLM | Lions Gate's private convertibles exchange challenged by Carl Icahn
|
| 7/20/2010 | CVLM | Lions Gate swaps shares for $100 million 3.625%, 2.9375% convertibles
|
| 3/16/2010 | BKCVHY | Moody's: Lions Gate may be pressured
|
| 3/8/2010 | CV | S&P: Lions Gate view to negative
|
| 2/17/2010 | CVHY | Lions Gate files $750 million shelf covering stock, debt securities
|
| 12/4/2009 | CV | Market Commentary: AMR, UAL extend gains; Take-Two holds up on hedge, stock sinks; King Pharma, Lions Gate up
|
| 10/15/2009 | BKCVHY | S&P rates Lions Gate notes B
|
| 4/21/2009 | CVSS | Icahn extends tender offer for Lions Gate's 2.9375%, 3.625% convertibles until May 1
|
| 3/19/2009 | CV | Icahn to launch tender offer for Lions Gate's convertibles
|
| 3/17/2009 | CV | Icahn prices tender offer for Lions Gate's convertibles
|
| 3/12/2009 | CV | Icahn planning tender offer for Lions Gate's convertibles
|
| 2/10/2009 | CV | Lions Gate buys back $9 million of its 3 5/8% notes
|
| 10/18/2006 | CV | Lionsgate calls 4.875% convertibles
|
| 9/22/2006 | CV | Market Commentary: Priceline climbs on debut; Lions Gate jumps on stock upgrade; Novell steady amid looming default
|
| 3/7/2005 | CV | Market Commentary: Genworth synthetic coming; Cell Therapeutics dives; Celgene rises; Saks bagged up; Lions Gate higher
|
| 2/22/2005 | CV | Market Commentary: Level 3 converts rise on private deal; UniSource, Allied Waste deals emerge; Par, Ivax, Teva up
|
| 2/18/2005 | CV | Market Commentary: Lions Gate, BlackRock, Sybase weak; Sepracor's older convertibles bleed; Fannie credit holding up
|
| 2/18/2005 | CV | New Issue: Lions Gate sells $150 million convertibles at 3.625%, up 38%
|
| 2/17/2005 | CV | Lions Gate $150 million overnight convertible talked to yield 3.125%-3.625%, up 38%-43%
|
| 2/17/2005 | CV | Market Commentary: BlackRock lifted; Lions Gate rolls out; Sepracor arbs hurt; REITs hit; Royal Caribbean call risk allayed
|
| 11/29/2004 | CV | Market Commentary: Retail paper weaker on mixed shopping figures; OMI bid up; American Equity deal emerges
|
| 10/4/2004 | CV | Lions Gate greenshoe exercised, raising convertibles to $150 million
|
| 9/29/2004 | CV | Market Commentary: Human Genome straddles par; Calpine's issue falls 3 points; Charter off; United Rentals up
|
| 9/29/2004 | CV | New Issue: Lions Gate $125 million convertible yields 2.9375%, up 36.5%
|
| 9/28/2004 | CV | Lions Gate overnight $125 million convertible talked at 2.375%-3.125% yield, up 36.5%
|
| 9/28/2004 | CV | Market Commentary: Human Genome up 1.5 in gray on tighter talk; Calpine, American Financial issues up; Lions Gate emerges
|
| 12/4/2003 | CV | Lions Gate greenshoe exercised, raising convertibles to $60 million
|
| 12/1/2003 | CV | New Issue: Lion's Gate $50 million convertible yields 4.875%, up 29.19%
|
| 11/25/2003 | CV | Lion's Gate $50 million convertible talked at 4.75-5.25%, up 25-30%
|
